[go: up one dir, main page]

PL2663318T3 - Kompozycja farmaceutyczna do leczenia raka - Google Patents

Kompozycja farmaceutyczna do leczenia raka

Info

Publication number
PL2663318T3
PL2663318T3 PL12702318T PL12702318T PL2663318T3 PL 2663318 T3 PL2663318 T3 PL 2663318T3 PL 12702318 T PL12702318 T PL 12702318T PL 12702318 T PL12702318 T PL 12702318T PL 2663318 T3 PL2663318 T3 PL 2663318T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
treating cancer
cancer
treating
pharmaceutical
Prior art date
Application number
PL12702318T
Other languages
English (en)
Inventor
Bakulesh Mafatlal Khamar
Indravadan Ambalal Modi
Original Assignee
Cadila Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmaceuticals Ltd filed Critical Cadila Pharmaceuticals Ltd
Publication of PL2663318T3 publication Critical patent/PL2663318T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL12702318T 2011-01-11 2012-01-10 Kompozycja farmaceutyczna do leczenia raka PL2663318T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN92MU2011 2011-01-11
PCT/IB2012/050120 WO2012095789A1 (en) 2011-01-11 2012-01-10 Pharmaceutical composition for treating cancer
EP12702318.2A EP2663318B1 (en) 2011-01-11 2012-01-10 Pharmaceutical composition for treating cancer

Publications (1)

Publication Number Publication Date
PL2663318T3 true PL2663318T3 (pl) 2015-08-31

Family

ID=54264167

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12702318T PL2663318T3 (pl) 2011-01-11 2012-01-10 Kompozycja farmaceutyczna do leczenia raka

Country Status (10)

Country Link
US (2) US20130295648A1 (pl)
EP (1) EP2663318B1 (pl)
JP (1) JP5889335B2 (pl)
CN (1) CN103338779B (pl)
AU (1) AU2012206322B2 (pl)
CA (1) CA2824417C (pl)
ES (1) ES2536842T3 (pl)
PL (1) PL2663318T3 (pl)
RU (1) RU2580888C2 (pl)
WO (1) WO2012095789A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2824417C (en) * 2011-01-11 2019-02-26 Cadila Pharmaceuticals Limited Mycobacterium w for use in treating cancer
JP6421208B2 (ja) * 2017-02-28 2018-11-07 カディラ ファーマシューティカルズ リミテッド がん抗原

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049751A1 (en) * 2001-12-10 2003-06-19 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
WO2003089462A2 (en) * 2002-04-16 2003-10-30 Jun Liu Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
US20100086911A1 (en) * 2005-03-03 2010-04-08 Ryosuke Katsuyama Preventive/therapeutic agent for cancer
US20100104536A1 (en) * 2007-03-20 2010-04-29 Indravadan Ambalal Modi P38 inhibitors
CA2824417C (en) * 2011-01-11 2019-02-26 Cadila Pharmaceuticals Limited Mycobacterium w for use in treating cancer
EP2729166B1 (en) * 2011-07-05 2017-09-06 Cadila Pharmaceuticals Limited Cancer antigen

Also Published As

Publication number Publication date
CN103338779A (zh) 2013-10-02
EP2663318A1 (en) 2013-11-20
CA2824417C (en) 2019-02-26
US20130295648A1 (en) 2013-11-07
JP2014502631A (ja) 2014-02-03
ES2536842T3 (es) 2015-05-29
RU2580888C2 (ru) 2016-04-10
CA2824417A1 (en) 2012-07-19
US9415078B2 (en) 2016-08-16
EP2663318B1 (en) 2015-03-18
WO2012095789A1 (en) 2012-07-19
AU2012206322B2 (en) 2016-09-01
JP5889335B2 (ja) 2016-03-22
US20150290255A1 (en) 2015-10-15
AU2012206322A1 (en) 2013-08-29
RU2013136780A (ru) 2015-02-20
CN103338779B (zh) 2015-12-23

Similar Documents

Publication Publication Date Title
HK1232158A1 (zh) 用於治療肝癌的藥物
IL234989B (en) Compounds and preparations containing them for the treatment of cancer
HUE044611T2 (hu) Gyógyászati készítmény rák kezelésére
PL2824114T3 (pl) Kompozycja farmaceutyczna do leczenia nowotworu
IL227429A0 (en) The components and methods of cancer treatment
AP3864A (en) Pharmaceutical composition
GB201118232D0 (en) Pharmaceutical composition
EP2635286A4 (en) METHOD FOR THE TREATMENT OF CANCER
IL228644A0 (en) Cancer treatment methods
HK1185874A1 (zh) 用於治療癌症的新的 -氨基- -羥基-苯甲酰胺
HK1189158A1 (en) Pharmaceutical composition
EP2774917A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
IL229231A0 (en) Preparations and methods for the treatment of cancer
SG11201400976WA (en) Methods and pharmaceutical compositions for treating cancer
ZA201503005B (en) Ingenol-derived compounds useful for treating cancer
HRP20180875T1 (hr) Kombinacijska terapija raka jajnika
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
HUP1100444A2 (en) Pharmaceutical composition
PL2663318T3 (pl) Kompozycja farmaceutyczna do leczenia raka
EP2785343A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA
EP2712621A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERPROLIFERATIVE DISEASES
EP2709623A4 (en) MEDICINES AND METHODS FOR TREATING CANCER
HUP1100445A2 (en) Pharmaceutical composition
HK1213809A1 (zh) 用於治療肥胖症的藥物組合物